Havn Life to provide naturally-derived psilocybin to ATMA Journey Facilities in Alberta and Nicoya Peninsula, Costa Rica
VANCOUVER, BC / ACCESSWIRE / Might 13, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the ‘Firm’ or ‘Havn Life’), a biotechnology firm pursuing standardized extraction of psychoactive compounds and the event of pure healthcare merchandise, is happy to announce it has entered right into a provide settlement (the ‘Provide Settlement’) with ATMA Journey Facilities Inc. – an Alberta-based firm centered on delivering revolutionary psychedelic-assisted therapies internationally – to be their unique provider of naturally-derived psilocybin.
ATMA Journey Facilities, positioned in Calgary, Central Alberta and Costa Rica, supply immersive, psychedelic-assisted journeys which can be purposefully designed for sufferers going through finish of life prognoses, in addition to for these affected by nervousness, melancholy and PTSD.
A pioneer within the Canadian psychedelics business, ATMA was the primary personal sector supplier to legally conduct psychedelic-assisted remedy utilizing psilocybin underneath a Part 56 exemption from Well being Canada. ATMA has simply acquired three further exemptions for sufferers, additional supporting that market demand for dependable, secure and naturally-derived psilocybin continues to develop.
With this Provide Settlement, Havn Life consolidates its place as an integral provide chain supplier of naturally-derived psychedelics for scientific suppliers and researchers.
‘We’re thrilled so as to add ATMA to our rising record of provide companions,’ says Havn Life CEO, Tim Moore. ‘Having agreements in place with Revive Therapeutics, The Heroic Hearts Mission, Well being Tech Connex and now ATMA, we’re seeing a surge in demand for scientific and lab use of naturally-derived compounds, properly underpinning our enterprise mannequin. As an growing variety of research help the efficacy of therapeutic psychedelics, the worldwide curiosity in these compounds can solely develop, and with our rising facility now totally operational in Jamaica, Havn Life is effectively positioned to satisfy this demand,’ he provides.
‘We’re more than happy to construct this relationship with Havn Life,’ says ATMA Co-CEO and Co-Founder, Vu Tran. ‘As our roster of sufferers continues to develop, our Journey Facilities would require a standardized and sustainable supply of naturally-derived psilocybin, and Havn Life is the perfect companion to fulfil this requirement,’ he provides.
Any transactions to be accomplished pursuant to the Provide Settlement, together with any provide of psilocybin thereunder, might be topic to compliance with any and all relevant legal guidelines and laws, together with these of Well being Canada.
On Behalf of The Board of Administrators
Chief Government Officer
About Havn Life Sciences Inc.
Havn Life Sciences is a Canadian biotechnology firm pursuing standardized extraction of psychoactive compounds, the event of pure healthcare merchandise, and revolutionary psychological well being therapy to help mind well being and improve the capabilities of the thoughts. Study extra at: havnlife.com and comply with us on Fb, Twitter, Instagram and Youtube.
About ATMA Journey Facilities Inc.
ATMA is a personal healthcare firm with the mission of delivering efficient and revolutionary therapeutic and transformative experiences that awaken the internal healer and promote a deeper reference to the self, with others, and with the fantastic thing about the world. ATMA was the primary personal sector service supplier in Canada to conduct authorized psychedelic-assisted remedy for a palliative care affected person underneath the approval of Well being Canada’s part 56(1) exemption. Discover out extra at Atmajourney.com.
Investor Relations: firstname.lastname@example.org 604 687 7130
Media: email@example.com 647 896-8078
Cautionary Be aware Concerning Ahead-Wanting Statements
Sure statements contained on this information launch, together with statements which can include phrases resembling ‘expects’, ‘anticipates’, ‘intends’, ‘plans’, ‘believes’, ‘estimates’, or related expressions, and statements associated to issues which aren’t historic details, resembling statements relating to the advantages of the Acquisition, the supposed use and advantages of the Facility, the flexibility of the Facility to facilitate an expanded product portfolio with sturdy income technology potential, develop potential to enter new NHP classes and scale back third occasion manufacturing burden, are forward-looking data throughout the that means of relevant securities legal guidelines. Such forward-looking statements mirror administration’s expectations and are primarily based on sure elements and assumptions and contain recognized and unknown dangers and uncertainties which can trigger the precise outcomes, efficiency, or achievements to be materially totally different from future outcomes, efficiency, or achievements expressed or implied by such forward-looking statements. These elements needs to be thought-about rigorously, and readers mustn’t place undue reliance on the Firm’s forward-looking statements. The Firm believes that the expectations mirrored within the forward-looking statements contained on this information launch are affordable, however no assurance will be provided that these expectations will show to be right, nor that the Acquisition will present the Firm the anticipated advantages, that the Facility might be utilized as supposed, or in any respect, that the Facility will be capable of facilitate an expanded product portfolio with sturdy income technology potential, develop potential to enter new NHP classes and scale back third occasion manufacturing burden. The Firm undertakes no obligation to launch publicly any future revisions to forward-looking statements to mirror occasions or circumstances after the date of this information or to mirror the prevalence of unanticipated occasions, besides as expressly required by regulation.
The CSE has not reviewed, authorised or disapproved the content material of this press launch
SOURCE: Havn Life Sciences Inc.
View supply model on accesswire.com: